Lantern Pharma Inc.LTRNNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
6.49%
↑ 145% above average
Average (26q)
-14.34%
Historical baseline
Range
High:51.19%
Low:-104.16%
Volatility
-1083.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 6.49% |
| Q2 2025 | 2.56% |
| Q1 2025 | 19.03% |
| Q4 2024 | -13.84% |
| Q3 2024 | 4.23% |
| Q2 2024 | 5.64% |
| Q1 2024 | -17.52% |
| Q4 2023 | -38.42% |
| Q3 2023 | 32.11% |
| Q2 2023 | -21.09% |
| Q1 2023 | -12.02% |
| Q4 2022 | -78.36% |
| Q3 2022 | 51.19% |
| Q2 2022 | -8.08% |
| Q1 2022 | -15.81% |
| Q4 2021 | 15.37% |
| Q3 2021 | -67.35% |
| Q2 2021 | -1.09% |
| Q1 2021 | 15.32% |
| Q4 2020 | -70.20% |
| Q3 2020 | -104.16% |
| Q2 2020 | -74.62% |
| Q1 2020 | 29.31% |
| Q4 2019 | -0.82% |
| Q3 2019 | -6.40% |
| Q2 2019 | -38.64% |
| Q1 2019 | 0.00% |